Short Communication Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/cardiology.2.034

Beta 3-Adrenergic Receptor (β3-AR) Activation at the End of Sustained Ischemia and/or Early Reperfusion may Prove to be a Valuable Cardioprotective Strategy

  • 1South African Medical Research Council, Biomedical Research and Innovation Platform, Cape Town Western Cape, South Africa
  • 2Stellenbosch University, Faculty of Medicine and Health Sciences, Division of Medical Physiology, Centre for Cardio-metabolic Research in Africa (CARMA), Cape Town, Western Cape, South Africa
+ Affiliations - Affiliations

Corresponding Author

Dr. Ruduwaan Salie, Ruduwaan.salie@mrc.ac.za

Received Date: August 01, 2022

Accepted Date: September 09, 2022


Myocardial ischemia; Reperfusion injury; Cardioprotection; β3-AR modulation

Author Information X